139 related articles for article (PubMed ID: 10422027)
1. Prevention of heterotopic ossification in hip arthroplasty. The influence of the duration of treatment.
Vastel L; Kerboull L; Dejean O; Courpied JP; Kerboull M
Int Orthop; 1999; 23(2):107-10. PubMed ID: 10422027
[TBL] [Abstract][Full Text] [Related]
2. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment.
Dorn U; Grethen C; Effenberger H; Berka H; Ramsauer T; Drekonja T
Acta Orthop Scand; 1998 Apr; 69(2):107-10. PubMed ID: 9602763
[TBL] [Abstract][Full Text] [Related]
4. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
5. Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.
Amstutz HC; Fowble VA; Schmalzried TP; Dorey FJ
J Arthroplasty; 1997 Feb; 12(2):126-32. PubMed ID: 9139094
[TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
Grohs JG; Schmidt M; Wanivenhaus A
Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
[TBL] [Abstract][Full Text] [Related]
7. Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty.
van der Heide HJ; Koorevaar RT; Schreurs BW; van Kampen A; Lemmens A
J Arthroplasty; 1999 Oct; 14(7):796-9. PubMed ID: 10537252
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of heterotopic ossification after total hip arthroplasty: a prospective randomized study comparing indomethacin and meloxicam.
Barthel T; Baumann B; Nöth U; Eulert J
Acta Orthop Scand; 2002 Dec; 73(6):611-4. PubMed ID: 12553505
[TBL] [Abstract][Full Text] [Related]
9. [Heterotopic ossifications].
Eulert J; Knelles D; Barthel T
Unfallchirurg; 1997 Aug; 100(8):667-74. PubMed ID: 9381216
[No Abstract] [Full Text] [Related]
10. Naproxen in the prevention of heterotopic ossification after total hip replacement.
Vielpeau C; Joubert JM; Hulet C
Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam.
van der Heide HJ; Spruit M; Slappendel R; Klooster N; van Limbeek J
Acta Orthop Belg; 2004 Jun; 70(3):240-6. PubMed ID: 15287403
[TBL] [Abstract][Full Text] [Related]
12. General short-term indomethacin prophylaxis to prevent heterotopic ossification in total hip arthroplasty.
Hofmann S; Trnka HJ; Metzenroth H; Frank E; Ritschl P; Salzer M
Orthopedics; 1999 Feb; 22(2):207-11. PubMed ID: 10037334
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial comparing early postoperative irradiation vs. the use of nonsteroidal antiinflammatory drugs for prevention of heterotopic ossification following prosthetic total hip replacement.
Kölbl O; Knelles D; Barthel T; Kraus U; Flentje M; Eulert J
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):961-6. PubMed ID: 9392532
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
Legenstein R; Bösch P; Ungersböck A
Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
[TBL] [Abstract][Full Text] [Related]
16. Indomethacin versus radiation therapy for heterotopic ossification after hip arthroplasty.
D'Lima DD; Venn-Watson EJ; Tripuraneni P; Colwell CW
Orthopedics; 2001 Dec; 24(12):1139-43. PubMed ID: 11770090
[TBL] [Abstract][Full Text] [Related]
17. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.
Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH
Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.
Romanò CL; Duci D; Romanò D; Mazza M; Meani E
J Arthroplasty; 2004 Jan; 19(1):14-8. PubMed ID: 14716644
[TBL] [Abstract][Full Text] [Related]
19. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
Gebuhr PH; Wilbek H; Soelberg M
Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
[TBL] [Abstract][Full Text] [Related]
20. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients.
Günal I; Hazer B; Seber S; Göktürk E; Turgut A; Köse N
Acta Orthop Scand; 2001 Oct; 72(5):467-9. PubMed ID: 11728072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
